PrognosisTumor Markers, BiologicalSurvival AnalysisSurvival RateNeoplasm StagingRetrospective StudiesMultivariate AnalysisDisease-Free SurvivalTreatment OutcomeKaplan-Meier EstimateProportional Hazards ModelsLymphatic MetastasisFollow-Up StudiesPredictive Value of TestsNeoplasm Recurrence, LocalImmunohistochemistryBreast NeoplasmsCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsRisk FactorsTime FactorsProspective StudiesNeoplasm InvasivenessAdenocarcinomaLung NeoplasmsNeoplasm MetastasisDisease ProgressionKi-67 AntigenChemotherapy, AdjuvantCohort StudiesAge FactorsCarcinoma, Squamous CellTissue Array AnalysisRecurrenceVincristineStomach NeoplasmsCarcinomaNeoplasm GradingLiver NeoplasmsGene Expression Regulation, NeoplasticCarcinoma, Non-Small-Cell LungMitotic IndexRisk AssessmentRemission InductionColorectal NeoplasmsLymph NodesKarnofsky Performance StatusReceptors, EstrogenBrain NeoplasmsReceptor, erbB-2Analysis of VarianceMelanomaCyclophosphamidePrednisoneRadiotherapy, AdjuvantDoxorubicinPloidiesReceptors, ProgesteroneNeoplasm ProteinsOvarian NeoplasmsImmunoenzyme TechniquesHodgkin DiseaseKidney NeoplasmsSarcomaEsophageal NeoplasmsSurvivalAntineoplastic AgentsLymph Node ExcisionSkin NeoplasmsCarcinoma, Ductal, BreastCarcinoma, Renal CellCarcinoma, HepatocellularBiological MarkersChi-Square DistributionL-Lactate DehydrogenaseBone NeoplasmsTumor Suppressor Protein p53Tumor BurdenNeoplasm, ResidualSeverity of Illness IndexLymphoma, Large B-Cell, DiffuseActuarial AnalysisLeukemia, Myeloid, AcuteBile Duct NeoplasmsGastrectomyAdenocarcinoma, MucinousMultiple MyelomaCholangiocarcinomaGene Expression ProfilingROC CurveLymphoma, Non-HodgkinDNA, NeoplasmCisplatinAcute DiseaseSoft Tissue NeoplasmsReverse Transcriptase Polymerase Chain ReactionRectal NeoplasmsSensitivity and SpecificityFluorouracilLeukemia, Lymphocytic, Chronic, B-Cell